Chronic Infantile Neurological Cutaneous Articular Syndrome - 7 Studies Found Terminated : Canakinumab to Treat Neonatal-Onset Multisystem Inflammatory Disease : NOMID CINCA Syndrome : 2008-10-09 : Drug: Canakinumab Completed : Efficacy and Safety of ACZ885 in Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease : Cryopyrin-Associated Periodic Syndromes Familial Cold Autoinflammatory Syndrome : 2008-05-27 : Drug: Canakinumab (ACZ885) 6 mL glass vial containing 150 mg lyophilized Canakinumab reconstituted with Completed : Efficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease : Cryopyrin-associated Periodic Syndromes Familial Cold Autoinflammatory Syndrome : 2011-02-22 : Drug: ACZ885 Completed : Efficacy and Safety Study of Canakinumab Administered for 6 Months (24 Weeks) in Japanese Patients With Cryopyrin-associated Periodic Syndromes Followed by an Extension Phase : Cryopyrin-associated Periodic Syndromes Familial Cold Autoinflammatory Syndrome : 2009-10-06 : Drug: canakinumab canakinumab Terminated : HL2351 CAPS Phase II Study : Cryopyrin‑Associated Periodic Syndromes (CAPS) : 2016-05-10 : Drug: HL2351 The dose will be adjusted based on disease activities Completed : The Safety and Efficacy of Canakinumab in Patients Aged 4 Years or Older Diagnosed With Cryopyrin-associated Periodic Syndromes (CAPS) in Canada : Cryopyrin Associated Periodic Syndrome : 2010-03-25 : Drug: canakinumab (company code: ACZ885D) Completed : Clinical Outcomes and Safety: A Registry Study of Ilaris (Canakinumab) Patients : Cryopyrin-associated Periodic Syndromes (CAPS) Familial Cold Autoinflam Syn (FCAS) : 2010-09-30
